2025-11-14T09:00:14-06:00 2024-12-31 991856619 GRANT THORNTON ADVISORS LLC 757 THIRD AVENUE 9TH FLOOR NEW YORK NY 100172013 990 2024-01-01 222803458 MUSCULOSKELETAL TRANSPLANT FOUNDATION INC MUSC 7326610202 125 MAY STREET EDISON NJ 088373264 DEBORAH ALLISON CHIEF FINANCIAL OFFICER 7326610202 2025-11-13 1 1 SCOTT THOMPSETT P00741490 2125990100 2025-11-13 2024 2025-03-06 01:10:19Z MTFBIOLOGICS JOSEPH A YACCARINO 125 MAY STREET EDISON NJ 088373264 511923653 0 X WWW.MTFBIOLOGICS.ORG X 1987 DC WE PROVIDE INNOVATIVE HUMAN BIOLOGIC SOLUTIONS THAT MAXIMIZE THE GIFT OF DONATION. 10 8 1309 14 898645 0 1041165 1005875 481035486 495952313 2903118 3871279 8492044 8648623 493471813 509478090 1000849 1270444 0 0 146999247 153355918 0 0 0 340670098 336517578 488670194 491143940 4801619 18334150 323206971 323446458 212992800 197128155 110214171 126318303 X SEE SCHEDULE O 0 0 446727711 1270444 495952313 MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES.IN 2024 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED (SEE SCHEDULE O)ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2024. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS,INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2024, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE.MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS.DURING 2024, MTF MAINTAINED ITS COMMITMENT TO ADVANCING KEY PROGRAMS, WITH SIGNIFICANT INVESTMENTS IN THE FOLLOWING AREAS:TISSUE RECOVERY AND PROCESSING: $203,669,233TISSUE DISTRIBUTION: $228,708,012RESEARCH AND DEVELOPMENT: $15,307,466THESE EFFORTS REFLECT MTF'S ONGOING DEDICATION TO SUPPORTING TISSUE DONATION, ENSURING EFFICIENT DISTRIBUTION, AND DRIVING INNOVATION THROUGH RESEARCH.OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES:1) WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS.2) WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS.3) WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE.4) WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2024, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2024.MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE.FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ DONORS-FAMILIES. STORIESABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ RECIPIENTS 446727711 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 1 1 0 1 1 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 346 0 1 1309 1 1 1 1 CA 0 0 0 0 0 0 0 0 0 0 X 10 8 0 0 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 CA GA NJ X DEBORAH ALLISON 7326610202 125 MAY ST EDISON NJ 08837 X WILLIAM W TOMFORD MD DIRECTOR 4.00 0.00 X 75000 0 0 DONALD HACKBARTH MD CHAIRMAN OF THE BOARD 1.00 0.00 X X 35000 0 0 DAVID KULBER MD DIRECTOR 1.00 0.00 X 31054 0 0 JOSEPH D ZUCKERMAN MD DIRECTOR 1.00 0.00 X 30000 0 0 JOSEPH A BUCKWALTER MD DIRECTOR 1.00 0.00 X 27500 0 0 SHARON GABRIELSON VICE CHAIR 1.00 0.00 X X 25000 0 0 JAN FINN RN MSN DIRECTOR 1.00 0.00 X 0 0 0 ALLAN GROSS MD NON-VOTING DIRECTOR 1.00 0.00 X 0 0 0 GERALD FINERMAN MD NON-VOTING DIRECTOR 1.00 0.00 X 0 0 0 DAVID R MCALLISTER MD DIRECTOR 1.00 0.00 X 27800 0 0 JEFFREY P ORLOWSKI DIRECTOR 1.00 0.00 X 23500 0 0 MIA TALMOR DIRECTOR 1.00 0.00 X 12000 0 0 JOSEPH A YACCARINO PRESIDENT / CEO 60.00 0.00 X 901884 0 56874 MICHAEL J KAWAS EXECUTIVE VP/ CFO 60.00 0.00 X 661023 0 36365 MARC LONG EXECUTIVE VP, R & D 60.00 0.00 X 494523 0 63083 JENNIFER BIRMINGHAM GENERAL COUNSEL 60.00 0.00 X 477283 0 56656 GEORGE HERRERA EXECUTIVE VP, DONOR SERVICES 60.00 0.00 X 456333 0 75143 MICHAEL OLECK EXECUTIVE VP, PROCESSING 60.00 0.00 X 429512 0 54512 BRIAN LEUTHNER VP AND GM PRS FRANCHISE 50.00 0.00 X 427269 0 56408 BRADLEY BAILEY VP AND GM ORTHO FRANCHISE 50.00 0.00 X 379683 0 51480 KIMBERLY A ROUNDS VP WOUND CAR 50.00 0.00 X 290209 0 0 SARAH BRUSCH EXECUTIVE SPECIALIST - STAR 50.00 0.00 X 476836 0 71027 FLOYD VAUGHAN EXECUTIVE SPECIALIST - STAR 50.00 0.00 X 458047 0 80338 NATHAN RICE SR. PORTFOLIO MANAGER 50.00 0.00 X 456446 0 72356 KEITH MOROCKO VP, CONTRACT ADMIN 50.00 0.00 X 406599 0 75941 GREGORY ADAMS NATIONAL SALES DIRECTOR, STAR 50.00 0.00 X 407106 0 64570 7009607 0 814753 307 0 1 0 ORTHOFIX US LLC 3451 PLANO PARKWAY LEWISVILLE TX 75056 TISSUE PROMO 52422736 CONMED CORPORATION 1250 TERMINUS DRIVE LITHIA SPRINGS GA 30122 TISSUE PROMO 32310627 DEPUY SYNTHES SALES INC 1302 WRIGHTS LANE EAST WEST CHESTER PA 19380 TISSUE PROMO 20959705 KOLOSIS BIO LLC 333 S RIO GRANDE ST SALT LAKE CITY UT 84101 TISSUE PROMO 14500215 CENTURION THERAPEUTICS INC PO BOX 175 MARSHFIELD HILLS MA 02051 TISSUE PROMO 9160509 228 1005875 1005875 DISTRIBUTION RIGHTS 621991 480459139 480459139 DONOR SCREENING 561421 8743075 8743075 DISTRIB. RIGHTS PAYMEN 900099 6750099 6750099 495952313 2610489 2610489 1324941 0 64151 1324941 -64151 1260790 1260790 3280057 2381412 898645 898645 DISTRIB. PARTNER REVEN 900099 4594544 4594544 FREIGHT & DELIVERY REV 900099 1504765 1504765 PARTNER REVENUE 900099 1068903 1068903 581766 581766 7749978 509478090 495952313 898645 11621257 1257244 1257244 13200 13200 5255094 4397269 857825 114085142 95462240 18622902 5388727 4509088 879639 20741086 17355377 3385709 7885869 6598605 1287264 1197691 1109964 87727 328603 328603 4620724 2635664 1985060 3020806 2922945 97861 1508176 93135 1415041 1321905 291053 1030852 4234540 4234540 11445913 11445913 3615002 3391811 223191 4125761 3566816 558945 1681188 1681188 4697463 3092326 1605137 1432258 1388398 43860 STORAGE & DISTRIBUTION 150842229 150808543 33686 0 PROCESSING COSTS 108202847 108202847 0 0 RECOVERY EXPENSES 14471067 14422879 48188 0 RESEARCH & DEVELOPMENT 4844247 4844247 0 0 14927158 3002419 11924739 491143940 446727711 44416229 0 0 0 67145530 65856996 66588579 60587502 101069887 109900311 2511719 3012922 137033353 101863948 35764285 35169405 4060000 4389864 46066971 44529458 323206971 323446458 65882508 55011660 2828492 3216826 85898673 79148574 14347641 17880061 44035486 41871034 212992800 197128155 X 110214171 126318303 110214171 126318303 323206971 323446458 X 18334150 -365778 -1864240 X 0 1 X 1 0 X 874610 929119 968850 1041165 1005875 4819619 412031487 454446555 466009432 481035486 495952313 2309475273 5549236 6852331 7242719 7192029 7749978 34586293 418455333 462228005 474221001 489268680 504708166 2348881185 0 0 0 2348881185 553522 149157 338308 3005099 2610489 6656575 553522 149157 338308 3005099 2610489 6656575 0 254880 0 1197034 898646 2350560 419008855 462632042 474559309 493470813 508217301 2357888320 0.99620 0.99680 0.00280 0.00250 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 40000 40000 0 SCHEDULE C, PART II-B, LINE 1 MTF DOES NOT MAKE POLITICAL CAMPAIGN DONATIONS. THE ORGANIZATION INDIRECTLY PARTICIPATED IN LOBBYING ACTIVITIES THROUGH MEMBERSHIP FEES PAID TO THE AMERICAN ASSOCIATION OF TISSUE BANK'S TISSUE POLICY GROUP. 6467468 6467468 60145172 46536308 13608864 51260623 39883449 11377174 19160090 15444191 3715899 35169405 RIGHT OF USE ASSETS 27283232 AFFILIATE RECEIVABLE 16640403 SECURITY DEPOSITS 465823 OTHER 140000 44529458 LEASE LIABILITY 27674591 OTHER LIABILITIES 8805705 DUE TO AFFILIATES 3459765 PARTNER ADVANCE 1930973 41871034 X 507274923 -365778 -1864896 -2230674 509505597 -27507 -27507 509478090 491171447 27507 27507 491143940 0 491143940 PART X, LINE 2: MTF FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. MTF HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. MTF HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024. PART XI, LINE 2D - OTHER ADJUSTMENTS: DEFERRED REVENUE - TIMING DIFFERENCE -957,000. AFS - OTHER G&A ADJUSTMENTS -482,570. DECREASE IN NET ASSETS FROM OPERATIONS BEFORE INSURANCE RECOVERY -425,326. PART XI, LINE 4B - OTHER ADJUSTMENTS: RECLASS LOSSES FROM SALE OF FIXED ASSETS -27,507. EAST ASIA & PACIFIC 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 7224747 EUROPE 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 3053031 NORTH AMERICA 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 2682798 MIDDLE EAST & NORTH AFRICA 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 829241 SOUTH AMERICA 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 363860 CENTRAL AMERICA & CARIBEAN 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 242482 SUB-SAHARAN AFRICA 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 77831 SOUTH ASIA 0 1 PROGRAM SERVICES TISSUE DISTRIBUTION 22901 0 8 0 0 0 8 14496891 0 14496891 1 0 0 0 0 0 1 CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 441067222 341018992 501(C)(3) 31250 0 SCIENTIFIC RESEARCH CLEMSON UNIVERSITY RESEARCH FOUNDATION PO BOX 946 CLEMSON SC 296330946 570750000 501(C)(3) 41667 0 SCIENTIFIC RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICK RD BALTIMORE MD 21211 520595110 501(C)(3) 16667 0 SCIENTIFIC RESEARCH NORTHWESTERN UNIVERSITY 750 N LAKESHORE DR 7TH FL CHICAGO IL 60611 362167817 501(C)(3) 25000 0 SCIENTIFIC RESEARCH OREGON STATE UNIVERSITY 312 KERR ADMINISTRATION BUILDING CORVALLIS OR 97331 611730890 501(C)(3) 41667 0 SCIENTIFIC RESEARCH ORTHOPAEDIC RESEARCH & EDUCATION FOUNDATION 9400 WEST HIGGINS ROAD SUITE 215 ROSEMONT IL 600184975 366009467 501(C)(3) 110000 0 SCIENTIFIC RESEARCH REGENTS OF THE UNIVERSITY OF CA LA 10833 LECONTE AVENUE BOX 956902 LOS ANGELES CA 90095 956006143 501(C)(3) 49000 0 SCIENTIFIC RESEARCH STEVENS INSTITUTE OF TECHNOLOGY 1 CASTLE POINT TERRACE HOBOKEN NJ 07030 221487354 501(C)(3) 62500 0 SCIENTIFIC RESEARCH THE BOARD OF TRUSTEES OF THE UNIVERSITY OF IL 28395 NETWORK PLACE CHICAGO IL 606731283 376000511 501(C)(3) 20833 0 SCIENTIFIC RESEARCH UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES 4301 W MARKHAM ST LITTLE ROCK AR 72205 716003252 501(C)(3) 17731 0 SCIENTIFIC RESEARCH UNIVERSITY OF CINCINNATI PO BOX 210222 CINCINNATI OH 452210222 316000989 501(C)(3) 25000 0 SCIENTIFIC RESEARCH UNIVERSITY OF MICHIGAN 930 N UNIVERSITY AVE ANN ARBOR MI 48108 386006309 501(C)(3) 33333 0 SCIENTIFIC RESEARCH UNIVERSITY OF MISSOURI PO BOX 807012 KANSAS CITY MO 641807012 436003859 501(C)(3) 20833 0 CAREER DEVELOPMENT UNIVERSITY OF OREGON PO BOX 3237 EUGENE OR 974030237 464727800 501(C)(3) 20833 0 SCIENTIFIC RESEARCH UNIVERSITY OF ROCHESTER 910 GENESEE STREET ROCHESTER NY 14611 160743209 501(C)(3) 66667 0 SCIENTIFIC RESEARCH VIRGINIA COMMONWEALTH UNIVERSITY 800 E LEUGH ST SUITE 3200 RICHMOND VA 23298 546001758 501(C)(3) 25000 0 SCIENTIFIC RESEARCH WAKE FOREST UNIVERSITY MEDICAL CENTER BOULEVARD WINSTONSALEM NC 27157 223849199 501(C)(3) 85700 0 SCIENTIFIC RESEARCH 17 0 STIPENDS FOR GRANT REVIEW 25 13200 PART I, LINE 2: PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS GRANTEE QUALIFICATIONS: GRANTS ARE AWARDED BY THE BOARD OF DIRECTORS IN THE FOLLOWING CATEGORIES: 1)ORTHOPEDIC RESEARCH GRANT: AWARDED THROUGH THE OREF (ORTHOPEDIC RESEARCH & EDUCATION FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO ALLOGRAFT SCIENCE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF ORTHOPEDIC RELATED INJURIES AND CONDITIONS, AND TO ENCOURAGE RESEARCH IN THE FIELD OF ORTHOPEDIC SURGERY IN THE MUSCULOSKELETAL SYSTEM THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. 2)PEER-REVIEW GRANTS: CLINICAL, SCIENTIFIC, AND TRANSLATIONAL RESEARCH GRANTS ARE AWARDED FOR THE CONTINUED RESEARCH TO DESIGN AND SUPPORT THE ADVANCEMENT OF ALLOGRAFT SCIENCE TO BOTH MEMBER AND NON-MEMBER ACADEMIC INSTITUTIONS. THERE ARE TWO LEVELS OF THIS TYPE OF GRANT: A) JUNIOR INVESTIGATOR AWARDS FOR NEW PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO $75,000 EACH FOR ONE YEAR, NON-RENEWABLE AND B) ESTABLISHED INVESTIGATOR AWARDS FOR EXPERIENCED PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO $83,333 EACH PER YEAR FOR UP TO THREE YEARS. IN ADDITION, PEER REVIEW GRANTS ARE SUBJECT TO REVIEW AND EVALUATED FOR QUALITY BY INDEPENDENT GRANT REVIEWERS. 3)ACADEMIC CAREER DEVELOPMENT: THIS AWARD IS INTENDED TO FOSTER THE DEVELOPMENT OF OUTSTANDING CLINICIANS AND ENABLE THEM TO EXPAND THEIR POTENTIAL TO MAKE SIGNIFICANT RESEARCH CONTRIBUTIONS TO THEIR CLINICAL FIELD. ONLY APPLICANTS FROM FOUNDATION MEMBER INSTITUTIONS ARE ELIGIBLE. AWARDS ARE FOR UP TO $83,333 EACH PER YEAR FOR UP TO THREE YEARS. RECIPIENTS OF MTF PEER REVIEW AND ACADEMIC CAREER DEVELOPMENT GRANT AWARDS WILL RECEIVE THEIR SUPPORT MADE IN INSTALLMENT PAYMENTS DURING THE GRANT PERIOD, WHICH MAY BE AS LONG AS SEVERAL YEARS. THE FINAL INSTALLMENT PAYMENT WILL BE MADE UPON RECEIPT OF A FINAL RESEARCH REPORT. A DETAILED BUDGET SHOWING USE OF ALL FUNDS AWARDED IS ALSO REQUIRED AS PART OF THE REPORT MADE TO MTF PRIOR TO THE RELEASE OF THE FINAL INSTALLMENT. TWO 6- MONTH, NO COST EXTENSIONS OF THE GRANT MAY BE FORMALLY REQUESTED. IF THE GRANT IS NOT COMPLETED BY THE AGREED COMPLETION DATE, THE GRANTEE WILL LOSE THE REMAINING INSTALLMENT OF THE GRANTED FUNDS. UNUSUAL CIRCUMSTANCES WILL BE CONSIDERED. 4)GRANT REVIEWER STIPENDS: GRANT REVIEWER STIPENDS ARE PAID TO INDEPENDENT REVIEWERS FOR REVIEWING AND EVALUATING FOR QUALITY THE PEER REVIEW AND ACADEMIC CAREER DEVELOPMENT GRANT PROPOSALS. 5)MTF BOD DIRECTED RESEARCH: PROJECTS DISCUSSED, AUTHORIZED, AND INITIATED BY THE BOARD OF DIRECTORS. INDIVIDUALS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS TYPE OF GRANT. INDIVIDUAL AMOUNTS VARY BASED ON THE BUDGET NECESSARY TO CONCLUDE THE RESEARCH INITIATIVE. 6) PLASTIC AND RECONSTRUCTIVE SURGERY RESEARCH GRANT: AWARDED THROUGH THE PSF (THE PLASTIC SURGERY FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO BIOLOGIC RECONSTRUCTION IN PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF INJURIES AND CONDITIONS IN THE FIELDS OF PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE, AND TO ENCOURAGE RESEARCH IN ALLOGRAFT SCIENCE IN THE FIELDS PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. ORGANIZATIONS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS GRANT. $100,000 (MAXIMUM) EACH. X X X X X 0 0 0 0 0 0 0 1 0 JOSEPH A YACCARINO PRESIDENT / CEO 740000 0 138480 0 23404 0 20700 0 36174 0 958758 0 0 0 MICHAEL J KAWAS EXECUTIVE VP/ CFO 571170 0 82030 0 7823 0 20700 0 15665 0 697388 0 0 0 MARC LONG EXECUTIVE VP, R & D 422263 0 72260 0 0 0 20645 0 42438 0 557606 0 0 0 SARAH BRUSCH EXECUTIVE SPECIALIST - STAR 100000 0 5000 0 371836 0 13322 0 57705 0 547863 0 0 0 FLOYD VAUGHAN EXECUTIVE SPECIALIST - STAR 100000 0 0 0 358047 0 18033 0 62305 0 538385 0 0 0 JENNIFER BIRMINGHAM GENERAL COUNSEL 412553 0 64730 0 0 0 20700 0 35956 0 533939 0 0 0 GEORGE HERRERA EXECUTIVE VP, DONOR SERVICES 394763 0 61570 0 0 0 20700 0 54443 0 531476 0 0 0 NATHAN RICE SR. PORTFOLIO MANAGER 176304 0 3553 0 276589 0 20700 0 51656 0 528802 0 0 0 MICHAEL OLECK EXECUTIVE VP, PROCESSING 387082 0 42430 0 0 0 20700 0 33812 0 484024 0 0 0 BRIAN LEUTHNER VP AND GM PRS FRANCHISE 355439 0 71830 0 0 0 20302 0 36106 0 483677 0 0 0 KEITH MOROCKO VP, CONTRACT ADMIN 342636 0 0 0 63963 0 17361 0 58580 0 482540 0 0 0 GREGORY ADAMS NATIONAL SALES DIRECTOR, STAR 213357 0 7500 0 186249 0 20700 0 43870 0 471676 0 0 0 BRADLEY BAILEY VP AND GM ORTHO FRANCHISE 328783 0 50900 0 0 0 19200 0 32280 0 431163 0 0 0 KIMBERLY A ROUNDS VP WOUND CAR 290209 0 0 0 0 0 0 0 0 0 290209 0 0 0 PART I, LINE 7 NON-FIXED PAYMENTS PROVIDED CERTAIN COMPONENTS OF EXECUTIVE COMPENSATION ARE NON-FIXED AND MAY VARY FROM YEAR TO YEAR BASED ON DISCRETIONARY FACTORS. THESE AMOUNTS ARE DESIGNED TO RECOGNIZE INDIVIDUAL AND ORGANIZATIONAL PERFORMANCE AND ARE DETERMINED AFTER CONSIDERATION OF THE FOUNDATION'S PROGRAMMATIC ACCOMPLISHMENTS, STRATEGIC PRIORITIES, AND OVERALL FINANCIAL AND MARKET CONDITIONS. THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IS RESPONSIBLE FOR REVIEWING, EVALUATING, AND APPROVING ALL NON-FIXED ELEMENTS OF COMPENSATION FOR THE FOUNDATION'S CHIEF EXECUTIVE OFFICER AND OTHER SENIOR EXECUTIVE OFFICERS. THE COMMITTEE'S DETERMINATIONS ARE GUIDED BY COMPARATIVE COMPENSATION DATA, PERFORMANCE EVALUATIONS, AND THE FOUNDATION'S COMPENSATION PHILOSOPHY TO ENSURE THAT ALL PAYMENTS ARE REASONABLE AND CONSISTENT WITH THE ORGANIZATION'S EXEMPT PURPOSES. X TISSUE FORMS 10590 0 0 0 0 PART I, LINE 33: THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF OR "THE FOUNDATION") RECOVERS, PROCESSES, AND DISTRIBUTES DONATED HUMAN TISSUES FOR USE IN TRANSPLANTATION, EDUCATION, AND RESEARCH. THESE TISSUES INCLUDE MUSCULOSKELETAL TISSUES (SUCH AS BONE, TENDON, LIGAMENT, AND CARTILAGE), DERMAL TISSUES, BIRTH TISSUE, AND CERTAIN NON-TRANSPLANTABLE ORGANS (SUCH AS LIVERS, HEARTS, AND LUNGS) USED SOLELY FOR RESEARCH. ALL ORGANS AND TISSUES ARE DONATED IN ACCORDANCE WITH FEDERAL AND STATE LAWS AND REGULATIONS, INCLUDING THE NATIONAL ORGAN TRANSPLANT ACT AND THE UNIFORM ANATOMICAL GIFT ACT. DONORS AND THEIR FAMILIES RECEIVE NO PAYMENT OR OTHER REMUNERATION FOR DONATIONS. TISSUES ARE RECOVERED EITHER DIRECTLY BY THE FOUNDATION OR THROUGH AFFILIATED ORGANIZATIONS (SUCH AS ORGAN PROCUREMENT ORGANIZATIONS OR EYE AND TISSUE BANKS) WITH WHICH THE FOUNDATION MAINTAINS FORMAL WRITTEN AGREEMENTS. THE FOUNDATION REIMBURSES THESE AFFILIATED ORGANIZATIONS FOR RECOVERY-RELATED COSTS. NO FINANCIAL VALUE IS ASSIGNED TO THE DONATED TISSUES OR ORGANS. COSTS ASSOCIATED WITH RECOVERY, PROCESSING, AND DISTRIBUTION ARE CAPITALIZED WHEN INCURRED AND FORM THE BASIS OF THE FOUNDATION'S INVENTORY AVAILABLE FOR TRANSPLANTATION AND RESEARCH. THE FOUNDATION THEN CHARGES SERVICE FEES TO COVER EXPENSES RELATED TO THE RECOVERY, PREPARATION, STORAGE, AND DISTRIBUTION OF TISSUES. FORM 990, PART I, LINE 1 THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF OR "THE FOUNDATION") IS DEDICATED TO PROVIDING HIGH-QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS, AND THEIR FAMILIES. MTF PROMOTES THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY: 1. MAXIMIZING THE AVAILABILITY OF HIGH-QUALITY HUMAN TISSUE, INCLUDING BONE, DERMAL, AND BIRTH TISSUE; 2. SUPPORTING MEDICAL, SCIENTIFIC, AND EDUCATIONAL RESEARCH RELATED TO TISSUE DONATION, RECOVERY, AND TRANSPLANTATION; AND 3. EDUCATING THE PUBLIC ABOUT THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. INCORPORATED ON JANUARY 30, 1987, AS A NONPROFIT MEMBERSHIP ORGANIZATION IN THE DISTRICT OF COLUMBIA, MTF IS RECOGNIZED AS A 501(C)(3) PUBLIC CHARITY. THE FOUNDATION WAS ESTABLISHED TO ADDRESS THE CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH, AND OCULAR TISSUE FOR TRANSPLANTATION. PROGRAMS AND NETWORK TO ACCOMPLISH ITS MISSION, MTF MAINTAINS A NATIONWIDE DONOR RECOVERY NETWORK, SUPPORTS DONOR AWARENESS PROGRAMS, DONATES BONE AND OTHER TISSUES FOR RESEARCH, PROVIDES RESEARCH GRANTS, AND ADVANCES BONE, SKIN, WOUND CARE, AND CARDIOVASCULAR TISSUE TRANSPLANTATION. THE FOUNDATION'S MEMBERSHIP CONSISTS ENTIRELY OF NONPROFIT 501(C)(3) ORGANIZATIONS, INCLUDING 42 ACADEMIC MEMBERS (ORTHOPEDIC TEACHING INSTITUTIONS) AND 31 RECOVERY ORGANIZATIONS (ORGAN, EYE, AND TISSUE PROCUREMENT ORGANIZATIONS) THROUGHOUT THE UNITED STATES. BIOCON, INC., A NONPROFIT 501(C)(3) ORGANIZATION, SERVES AS THE SOLE CORPORATE MEMBER OF THE FOUNDATION. MTF'S NATIONWIDE DONOR RECOVERY NETWORK, OPERATED THROUGH ITS MEMBER ORGANIZATIONS, ENSURES THAT THE PUBLIC CAN QUICKLY ACCESS NEEDED ALLOGRAFT TISSUE. ALL TISSUE RECOVERED THROUGH THIS NETWORK IS SCREENED ACCORDING TO STANDARDIZED CRITERIA ESTABLISHED BY MTF'S MEDICAL BOARD OF TRUSTEES AND DONATION BOARD OF TRUSTEES. THE FOUNDATION ALSO MAINTAINS A RIGOROUS QUALITY ASSURANCE PROGRAM ALIGNED WITH THE POLICIES OF THE AMERICAN ASSOCIATION OF TISSUE BANKS, THE U.S. FOOD & DRUG ADMINISTRATION, AND OTHER INTERNATIONAL REGULATORY AGENCIES. IN ADDITION, MTF PROVIDES FUNDING, TRAINING, AND EDUCATIONAL SUPPORT TO RECOVERY ORGANIZATIONS, HOSPITALS, AND THE GENERAL PUBLIC TO ENHANCE DONOR AWARENESS AND BEST PRACTICES IN TISSUE RECOVERY. MEMBERSHIP AND GOVERNANCE UNDER ARTICLE III OF THE FOUNDATION'S BYLAWS, MEMBERSHIP IS OPEN TO ACADEMIC MEDICAL INSTITUTIONS WITH ACCREDITED RESIDENCY PROGRAMS, FEDERALLY CHARTERED ORGAN PROCUREMENT ORGANIZATIONS (OPOS), AND EYE OR TISSUE BANKS. ALL MEMBERS SUPPORT MTF'S MISSION THROUGH SERVICE AND SUPPLY AGREEMENTS. THE FOUNDATION IS GOVERNED BY A 12-MEMBER BOARD OF DIRECTORS (PLUS TWO NON-VOTING EMERITUS MEMBERS), COMPOSED PRIMARILY OF RECOGNIZED EXPERTS IN HEALTHCARE, SCIENCE, AND TRANSPLANTATION. TWO MEMBERS EACH FROM THE MEDICAL BOARD AND THE DONATION BOARD OF TRUSTEES ALSO SERVE ON THE BOARD OF DIRECTORS. THE MEDICAL BOARD OF TRUSTEES PROVIDES GUIDANCE ON RESEARCH PRIORITIES, GRANT DISTRIBUTION, AND CLINICAL STANDARDS RELATED TO TISSUE SCREENING, RECOVERY, TESTING, AND DISTRIBUTION. THE DONATION BOARD OF TRUSTEES ADVISES THE FOUNDATION ON DONATION AND RECOVERY PRACTICES AND ENSURES THAT THE ORGANIZATION'S PROCEDURES REFLECT THE HIGHEST ETHICAL AND OPERATIONAL STANDARDS. FUNDING AND RESEARCH MTF FUNDS ALL COSTS ASSOCIATED WITH DONOR TISSUE RECOVERY, SUPPORTED PRIMARILY THROUGH SERVICE FEES DESIGNED TO COVER EXPENSES AND FUND ONGOING RESEARCH. WHEN POSSIBLE, THE FOUNDATION PROVIDES TISSUE AT REDUCED OR NO COST FOR CHARITABLE, EDUCATIONAL, OR RESEARCH PURPOSES CONDUCTED BY 501(C)(3) ORGANIZATIONS. ANY SURPLUS FUNDS ARE REINVESTED TO SUBSIDIZE THE COST OF TISSUE FOR THOSE IN NEED, SUPPORT EDUCATION AND RESEARCH INITIATIVES, MAINTAIN INFRASTRUCTURE, AND BUILD RESERVES NECESSARY FOR FUTURE PROGRAM EXPANSION. MTF SUPPORTS NUMEROUS RESEARCH AND EDUCATIONAL PROGRAMS THAT ADVANCE TRANSPLANT SCIENCE. THESE INCLUDE GRANTS FOR PROJECTS IN TISSUE DONATION AND APPLICATION, CONTINUING MEDICAL EDUCATION (CME) COURSES FOR SURGEONS AND NURSES, AND EDUCATIONAL PARTNERSHIPS WITH ORTHOPEDIC TEACHING HOSPITALS ACROSS THE UNITED STATES. FORM 990, PART I LINE 6 COMPASSIONATE CARE FOR DONOR FAMILIES IS AT THE HEART OF OUR MISSION AT MTF THE DONOR FAMILY SUPPORT SERVICES VOLUNTEERS NEVER FORGETS THE MAGNITUDE OF THE GIFT OUR DONORS AND THEIR FAMILIES MAKE. WE'VE SET THIS SITE UP JUST FOR YOU, A PLACE YOU CAN COME TO LEARN ABOUT TISSUE DONATION, FIND HELPFUL RESOURCES AND MORE. WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/DONORS-FAMILIES OUR VOLUNTEERS ARE THERE TO HELP YOU COPE WITH YOUR LOSS, WHILE APPRECIATING THE INCREDIBLE GIFT YOUR LOVED ONE HAS MADE TO OTHERS INCLUDING PERIODIC PERSONAL PHONE CALLS, REMEMBRANCES INCLUDING SYMPATHY CARDS, FREE INFORMATIVE PACKET WITH BEREAVEMENT SUPPORT LITERATURE, SUPPORT GROUP INFORMATION AND MORE. MTF VOLUNTEER GROUPS COMPRISED OF DONOR FAMILY MEMBERS AND BIRTH TISSUE DONORS WHO SHARE THEIR STORIES AND ENCOURAGE OTHERS TO CONSIDER DONATION. MANY FAMILIES HAVE FOUND THAT BEING INVOLVED WITH OTHER DONOR FAMILIES HAS A PROFOUND EFFECT ON THEIR LIVES AND APPRECIATE THE OPPORTUNITY TO SHARE THE STORY OF THEIR LOVED ONES. TISSUE RECIPIENTS HAVE INSPIRATIONAL STORIES OF HOW A TRANSPLANT TRANSFORMED THEIR LIVES. OUR VOLUNTEERS ARE LOCATED THROUGHOUT THE COUNTRY. WE CAN PROVIDE YOU WITH INFORMATION ON HOW YOU CAN GET INVOLVED AND VOLUNTEER BY CONTACTING VOLUNTEERS@MTF.ORG. THE LINKING LIVES PROGRAM IS A VOLUNTARY PROGRAM THAT GIVES TISSUE RECIPIENTS THE OPPORTUNITY TO WRITE A LETTER OF THANKS TO THEIR DONOR FAMILY. RECIPIENTS ARE ENCOURAGED TO WRITE A LETTER WHICH MTF WILL FORWARD TO THE AGENCY THAT COORDINATED THE TISSUE RECOVERY. WE PROVIDE TISSUE RECIPIENTS WITH GUIDELINES FOR WRITING TO THEIR DONOR FAMILY. THE RECOVERY AGENCY SENDS THE LETTER TO THE DONOR FAMILY. DONOR FAMILIES MAY NOT HEAR FROM THEIR TISSUE RECIPIENTS AS MANY PATIENTS ARE UNAWARE THAT THEY CAN WRITE TO THEIR DONOR FAMILIES. HOWEVER, THOSE WHO DO RECEIVE A LETTER FROM A GRATEFUL TISSUE RECIPIENT HAVE SHARED HOW IMPORTANT THOSE LETTERS CAN BE. FORM 990, PART VI, SECTION A, LINE 4 IN JUNE 2025, THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. AMENDED ITS BYLAWS TO IMPLEMENT SEVERAL SIGNIFICANT GOVERNANCE CHANGES. KEY UPDATES INCLUDE: 1) EXPANSION OF THE FOUNDATION'S STATED PURPOSES TO INCLUDE REGENERATIVE MEDICINE, MEDICAL DEVICES, DONOR AWARENESS PROGRAMS, AND BROADER CLINICAL APPLICATIONS. 2) CLARIFICATION OF MEMBERSHIP STRUCTURE, SPECIFYING BIOCON, INC. AS THE SOLE CORPORATE MEMBER WITH EXCLUSIVE VOTING RIGHTS FOR PURPOSES OF NONPROFIT LAW. 3) SIGNIFICANT EXPANSION AND CLARIFICATION OF THE BOARD OF DIRECTORS' POWERS, INCLUDING EXPLICIT APPROVAL AUTHORITY OVER FINANCIAL PLANS, BUDGETS, INVESTMENTS, STRATEGIC PLANS, MERGERS, SUBSIDIARY FORMATION, MAJOR TRANSACTIONS, CHARITABLE CONTRIBUTIONS, LOANS, AUDITED FINANCIALS, AND ACTIONS AFFECTING TAX-EXEMPT STATUS. 4) REMOVAL OF THE PRIOR "CLASS" STRUCTURE FOR DIRECTORS AND CLARIFICATION OF DIRECTOR TERM FILLING AND SUCCESSION. 5) ENHANCED COMMITTEE STRUCTURES AND ROLES, INCLUDING EXPANDED RESPONSIBILITIES FOR AUDIT, GOVERNANCE, RESEARCH, COMPENSATION, AND EXECUTIVE COMMITTEES. 6) UPDATED OFFICER APPOINTMENT AND REMOVAL PROCEDURES, WITH MORE DETAILED STANDARDS OF CONDUCT FOR OFFICERS AND DIRECTORS. 7) ADDITION OF EXPLICIT INDEMNIFICATION AND LIABILITY LIMITATIONS FOR VOLUNTEERS AND EMPLOYEES, TIED TO INSURANCE COVERAGE. 8) STRENGTHENED CONFLICT-OF-INTEREST POLICIES AND PROCEDURES, INCLUDING STRICTER QUORUM RULES FOR INTERESTED DIRECTORS. 9) CLARIFIED AMENDMENT PROCEDURES, INCLUDING REQUIREMENTS FOR NOTICE, VOTING THRESHOLDS, AND RATIFICATION BY THE SOLE CORPORATE MEMBER. THESE AMENDMENTS WERE ADOPTED TO REFLECT CURRENT PRACTICES, REGULATORY REQUIREMENTS, AND BEST PRACTICES IN NONPROFIT GOVERNANCE. FORM 990, PART VI, SECTION A, LINE 6 MTF IS ORGANIZED WITH TWO CLASSES OF MEMBERSHIP WHICH ARE (1) NONCORPORATE MEMBERSHIP AND (2) CORPORATE MEMBERSHIP. THE NON-CORPORATE MEMBERS INCLUDE ACADEMIC MEMBERS, RECOVERY MEMBERS AND RESEARCH MEMBERS. THE SOLE CORPORATE MEMBER OF MTF IS BIOCON, INC. FORM 990, PART VI, SECTION A, LINE 7A ELECTION OF MEMBERS AND THEIR RIGHTS THE SOLE CORPORATE MEMBER MAY APPOINT ALL DIRECTORS SUBJECT TO THE FOLLOWING: THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "MEDICAL BOARD OF TRUSTEES" WILL BE APPOINTED TO THE BOARD. ALSO, THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "DONATION BOARD OF TRUSTEES" WILL BE APPOINTED MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B DECISIONS SUBJECT TO APPROVAL OF MEMBERS ANY CHANGES THAT ARE A MATERIAL CHANGE TO THE GOVERNING DOCUMENTS OF THE FOUNDATION (EX.BY-LAWS OR ARTICLES OF INCORPORATION) MUST BE APPROVED BY THE MEMBERS OF THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND THE DONATION BOARD OF TRUSTEES. FINAL APPROVAL OF THESE CHANGES MUST BE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B ORGANIZATION'S PROCESS TO REVIEW FORM 990 MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE AUDIT COMMITTEE MEETING, THE FORM 990 IS THEN CIRCULATED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C ENFORCEMENT OF CONFLICTS POLICY MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. MTF IS DILIGENT IN REVIEWING THE ANNUAL DISCLOSURE FORMS SUBMITTED BY THE COVERED PERSONS, AND IN SCREENING, COMPILING AND MAINTAINING THE SUBMISSIONS. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION PROCESS FOR TOP OFFICIAL EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR OUR EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN JULY 2023, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY JULY 2023), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW: MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS DISCLOSURE EXPLANATION MTF MAKES ITS FORM 990 AND OTHER PUBLIC DOCUMENTS AVAILABLE TO THE PUBLIC AT ITS REGULAR PLACE OF BUSINESS IN PERSON, REQUESTS THROUGH EMAIL OR VIA US POSTAL SERVICE. IN ADDITION, FORM 990 IS AVAILABLE ON THE INTERNET AT WWW.GUIDESTAR.ORG. FORM 990, PART VII-A BOARD OF DIRECTORS COMPENSATION MEMBERS OF THE BOARD OF DIRECTORS ARE COMPENSATED FOR THEIR SERVICE ON THE BOARD THROUGH THE PAYMENT OF DIRECTOR FEES. THESE FEES RECOGNIZE THE TIME, EXPERTISE, AND FIDUCIARY RESPONSIBILITIES ASSOCIATED WITH BOARD SERVICE, INCLUDING PARTICIPATION IN BOARD AND COMMITTEE MEETINGS, REVIEW OF STRATEGIC INITIATIVES, AND OVERSIGHT OF THE ORGANIZATION'S FINANCIAL AND PROGRAMMATIC PERFORMANCE. THE AMOUNT OF FEES PAID TO EACH DIRECTOR IS DETERMINED ANNUALLY AND APPROVED BY THE BOARD'S GOVERNANCE (OR COMPENSATION) COMMITTEE BASED ON A REVIEW OF COMPARABLE DATA FROM SIMILARLY SIZED NONPROFIT ORGANIZATIONS. DIRECTORS RECEIVE NO ADDITIONAL COMPENSATION FOR COMMITTEE PARTICIPATION UNLESS NOTED. IN ADDITION TO ANY BOARD FEES THEY MAY HAVE RECEIVED, TWO BOARD DIRECTORS, WILLIAM TOMFORD AND DAVID KUBLER, RECEIVED COMPENSATION FOR ADDITIONAL SERVICES THEY PROVIDED TO MTF. BY VIRTUE OF THIS ANCILLARY COMPENSATION, BOTH BOARD MEMBERS ARE DEEMED NON-INDEPENDENT FOR 990 PURPOSES. EXPENSE REIMBURSEMENTS ARE PROVIDED FOR COSTS INCURRED TO ATTEND BOARD MEETINGS AND OTHER MTF FUNCTIONS. ALL SUCH ARRANGEMENTS ARE SUBJECT TO REVIEW AND APPROVAL TO ENSURE COMPLIANCE WITH APPLICABLE POLICIES AND REGULATIONS. FORM 990, PART XI, LINE 9: DEFERRED REVENUE - TIMING DIFFERENCE -957,000. DECREASE IN NET ASSETS FROM OPERATIONS BEFORE INSURANCE RECOVERY -425,326. OTHER G&A ADJUSTMENTS -482,570. MISC. ADJUSTMENTS 656. BIOCON INC 125 MAY STREET EDISON NJ 08837 223619257 HOLDING CO DC 501(C)3 12B N/A 0 DEUTCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH (DIZG GMBH) INNOVATIONSPK W M-V-ARDN BLDG 42 BERLINE GM TISSUE DISTRIBUTION GM BIOCON C 0 1 0 0 1 0 0 1 1 0 0 1 1 0 1 1 0 0 0 1 DIZG GMBH A 9000 ACCT BOOKS / RECORDS DIZG GMBH D 1548050 ACCT BOOKS / RECORDS DIZG GMBH G 637000 ACCT BOOKS / RECORDS BIOCON INC K 4649460 ACCT BOOKS / RECORDS BIOCON INC L 611381 ACCT BOOKS / RECORDS SCHEDULE R - PART II BIOCON INC, A TAX-EXEMPT ORGANIZATION SERVES AS THE SOLE CORPORATE MEMBER OF MTF. BIOCON THROUGH ITS DISREGARDED ENTITIES OWNS OPERATES AND LEASES PROPERTY TO MTF. PART V, LINE 2(1) - 2(4): DURING 2024, DIZG REIMBURSED MTF INTEREST AND PRINCIPAL OF $9,000 AND $1,548,050, RESPECTIVELY; MTF DISTRIBUTED DONORS TO DIZG IN THE AMOUNT $637,000 AND MTF LOANED DIZG $0. GIVEN THESE CIRCUMSTANCES NO FORM 926 WAS DEEMED NECESSARY.